NIH PAR · NIGMS · UC2

PAR-24-268: Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program (UC2- Clinical Trial Not Allowed)

Reviewed by Dr. Meng ZhaoLast reviewed October 16, 2026Data refreshed October 16, 2026Editorial standards

Open for applicationsNext due date: Jan 27, 2027Expires Jan 28, 2027

The Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program aims to promote broad participation in the biomedical research ecosystem by supporting resource limited organizations to conduct research, enhance the research environment, and increase sponsored programs administration capacity.This program intends to support eligible, domestic organizations with limited research resources and few biomedical doctoral students.

Full NOFO in the NIH Guide Apply on Grants.gov

NOFO number
PAR-24-268
Type
PAR
Activity code
UC2
Primary institute
NIGMS · National Institute of General Medical Sciences
Clinical trials
Not Allowed
Posted
Oct 30, 2024
Opens
Dec 27, 2024
Expires
Jan 28, 2027

PAR-24-268 due dates

1 application due date remains before the NOFO expires. Dates marked * are NIH standard due dates. Check the related notices below for changes NIH made after posting.

Application due dates and review cycles for PAR-24-268
Application Due Date(s)Renewal / Resubmission / Revision (as allowed)AIDS - New/Renewal/Resubmission/Revision, as allowedScientific Merit ReviewAdvisory Council ReviewEarliest Start Date
February 19, 2025Not ApplicableNot ApplicableJuly 2025October 2025December 2025
January 27, 2026Not ApplicableNot ApplicableJuly 2026October 2026December 2026
January 27, 2027Not ApplicableNot ApplicableJuly 2027October 2027December 2027

Projects funded under PAR-24-268

NIH RePORTER lists 6 projects funded under PAR-24-268 in FY2022–FY2026, with $4.2M in award dollars. Counts include each project's later non-competing years, which keep the original NOFO number.

Projects funded

6

Distinct projects, FY2022–FY2026

New awards

6

Type 1 (new project) award records

NIH funding

$4.2M

Award dollars under PAR-24-268, FY2022–FY2026

Funding by fiscal year

Award records, new awards, and funding by fiscal year under PAR-24-268
Fiscal yearAward recordsNew awardsFunding
FY202200$0
FY202300$0
FY202400$0
FY202511$570K
FY202665$3.6M

Institutions with the most funding

  1. University of the Virgin Islands$1.2M · 1 project
  2. University of Minnesota Duluth$760K · 1 project
  3. Meharry Medical College$684K · 1 project
  4. Western Washington University$599K · 1 project
  5. Auburn University at Montgomery$555K · 1 project
  6. Xavier University$389K · 1 project

Funding institutes

  • NIGMS$4.2M · 7

Activity codes funded

  • UC27 records

Most recent new awards

FY2026 closed on September 30, 2026, but NIH keeps posting that year's awards to RePORTER for several weeks. FY2026 figures reflect records available on October 16, 2026 and may rise slightly at the next refresh.

Participating institutes

11 NIH institutes and offices take applications under PAR-24-268. Contact the program officer at the institute that fits your research before applying.

  • NIGMS · National Institute of General Medical Sciences
  • NEI · National Eye Institute
  • NIA · National Institute on Aging
  • NIAAA · National Institute on Alcohol Abuse and Alcoholism
  • NIAMS · National Institute of Arthritis and Musculoskeletal and Skin Diseases
  • NIDCR · National Institute of Dental and Craniofacial Research
  • NIDA · National Institute on Drug Abuse
  • NIMH · National Institute of Mental Health
  • NINDS · National Institute of Neurological Disorders and Stroke
  • NCCIH · National Center for Complementary and Integrative Health
  • ODSS

Related notices

  1. Mar 31, 2025

    This funding opportunity was updated to align with agency priorities. Carefully reread the full funding opportunity and make any needed adjustments to your application prior to submission.

  2. Dec 6, 2024 · NOT-GM-25-010

    Notice of Virtual Question & Answer Office Hours for Biomedical Research Environment & Sponsored Programs Administration Development BRE-SPAD) Program Applicants.

  3. Nov 15, 2024 · NOT-GM-25-010

    Notice of Change to First Application Due Date for PAR-24-268 Biomedical Research Environment & Sponsored Programs Administration Development BRE-SPAD) Program UC2- Clinical Trial Not Allowed)".

  4. Nov 4, 2024 · NOT-GM-25-007

    Notice of Informational Webinar for PAR-24-268 Biomedical Research Environment & Sponsored Programs Administration Development BRE-SPAD) Program UC2- Clinical Trial Not Allowed)". See Notice NOT-GM-25-007.April 4, 2024 - Overview of Grant Application and Review Changes for Due Dates on or…

  5. Aug 31, 2022 · NOT-OD-22-198

    Implementation Changes for Genomic Data Sharing Plans Included with Applications Due on or after January 25, 2023. See Notice NOT-OD-22-198.

  6. Aug 5, 2022 · NOT-OD-22-189

    Implementation Details for the NIH Data Management and Sharing Policy. See Notice NOT-OD-22-189.

Award terms

Application types allowed
New The OER Glossary and the How to Apply Application Guide provide details on these application types. Only those application types listed here are allowed for this NOFO.
Award budget
Application budgets for direct costs should not exceed 500,000/year.
Project period
The maximum project period is five years. The scope of the proposed project should determine the project period. NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made from this NOFO.
Funds available and number of awards
The number of awards is contingent upon NIH appropriations and the number of meritorious applications submitted.

Summarized from the NOFO text; the full NOFO governs eligibility, budget, and review.

About this page

GotGrant gathers the NOFO, its participation and change notices, and its NOSIs from the NIH Guide for Grants and Contracts, and counts funded projects from NIH RePORTER by the opportunity number each award was made under. Data refreshed October 16, 2026; the NIH Guide is the authoritative source. See our data methodology.

Find who wins under this NOFO